| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 2.13B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LP6.F returned +25.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +60.6% |
| 1 year | +25.5% |
| 5 years | +2162.7% |
| 10 years | +52239.1% |
| All-time high | €4.50 (Jun 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in LP6.F would be worth today ›Yes. Livzon Pharmaceutical Group Inc. paid 1 dividend over the past 12 months. The most recent was €0.18 per share on Jun 16, 2026. The dividend yield is 7.60%.
Livzon Pharmaceutical Group Inc. is part of the Healthcare sector.
Livzon Pharmaceutical Group Inc. has a market cap of 2.04B EUR, based on the latest quote.
Livzon Pharmaceutical Group Inc. is expected to report earnings around Oct 22, 2026. That date is an estimate and has not been confirmed by the company.
